Induction of apoptosis and growth inhibition by silodosin and abiraterone acetate in PC-3 human prostate cancer cells

Purpose: Prostate cancer that progresses despite androgen deprivation therapy, known as metastatic castration-resistant prostate cancer (mCRPC) is notoriously difficult to treat. While abiraterone acetate (AA) is a standard therapy, repurposing drugs like silodosin, a selective α1A-adrenoceptor anta...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Lukman Hakim, Zakaria Aulia Rahman, Furqan Hidayatullah, Anthony Chi-Fai Ng
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Korean Urological Association 2025-11-01
Edice:	Investigative and Clinical Urology
Témata:	abiraterone acetate in vitro techniques prostatic neoplasms silodosin
On-line přístup:	https://www.icurology.org/pdf/10.4111/icu.20250310
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!